HLA class I-T cell epitopes from trans-sialidase proteins reveal functionally distinct subsets of CD8+ T cells in chronic Chagas disease

PLoS Neglected Tropical Diseases

Volumn 2, Issue 9, 2008, Pages

  Alvarez, María G ^a   Postan, Miriam ^b   Weatherly, D Brent ^c   Albareda, Maria C ^b   Sidney, John ^d   Sette, Alessandro ^d   Olivera, Carina ^b   Armenti, Alejandro H ^a   Tarletona, Rick L ^c   Laucella, Susana A ^b  

^a Hospital Interzonal General de Agudos Eva Peronquot   (Argentina)

^b Instituto Nacional de Diagnostico e Investigacion de la Enfermedad de Chagas Dr Mario Fatala Chaben   (Argentina)

^c UNIVERSITY OF GEORGIA   (United States)

^d LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; EPITOPE; GAMMA INTERFERON; HLA A ANTIGEN; HLA A24 ANTIGEN; HLA ANTIGEN CLASS 1; HLA B44 ANTIGEN; HLA B7 ANTIGEN; INTERLEUKIN 2; SIALIDASE; GLYCOPROTEIN; HLA A0201 ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA-A0201 ANTIGEN; TRANS SIALIDASE; TRANS-SIALIDASE;

ADULT; ANTIGEN BINDING; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ANTIGENICITY; ARTICLE; BIOINFORMATICS; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHAGAS DISEASE; CONTROLLED STUDY; CYTOKINE RELEASE; HAPLOTYPE; HLA TYPING; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; MAJOR CLINICAL STUDY; MULTIGENE FAMILY; NONHUMAN; PARASITE IMMUNITY; PREDICTION; T LYMPHOCYTE SUBPOPULATION; TRYPANOSOMA CRUZI; ANIMAL; CENTRAL AMERICA; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HEMAGGLUTINATION; IMMUNOLOGY; MIDDLE AGED; SOUTH AMERICA; T LYMPHOCYTE;

ADULT; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CENTRAL AMERICA; CHAGAS DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES, T-LYMPHOCYTE; GLYCOPROTEINS; HEMAGGLUTINATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HLA-A ANTIGENS; HLA-B ANTIGENS; HUMANS; INTERFERON-GAMMA; MIDDLE AGED; NEURAMINIDASE; SOUTH AMERICA; T-LYMPHOCYTES; TRYPANOSOMA CRUZI;

EID: 56149089459     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000288     Document Type: Article

References (59)

1. Bank/WHO, U.W., UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (1995) In Twelfth Programme Report of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR). World Health Organization Geneva. pp 125-134.
2. Feldman AM, McNamara D (2000) Myocarditis. N. Engl. J. Med. 343: 1388-98.
3. Tarleton RL, Koller BH, Latour A, Postan M (1992) Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature 356: 338-40.
4. Tarleton RL, Sun J, Zhang L, Postan M (1994) Depletion of T-cell subpopulations results in exacerbation of myocarditis and parasitism in experimental Chagas' disease. Infect Immun 62: 1820-9.
5. Tarleton RL, Zhang L, Chagas Disease Etiology (1999) Chagas Disease Etiology: Autoimmunity or parasite persistence?. Parasitol. Today 15: 94-99.
6. Tarleton RL (2001) Parasite persistence in the aetiology of Chagas disease. Int J Parasitol 31: 549-53.
7. Laucella SA, Postan M, Martín D, Hubby Fralish B, et al. (2004) The frequency of IFN-gamma T cells especific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease. J. Infec. Dis. 189: 909-918. 2004.
8. + T cells in chronic Chagas disease patients. Internat Immunol 18: 465-71.
9. Yewdell JW, Bennink JR (1999) Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu. Rev. Immunol. 17: 51-88.
10. Sette A, Fikes J (2003) Epitope-based vaccines: an update on epitope identification, vaccine design and delivery. Current Opinion in Immunol 15: 461-470.
11. + T cell responses. Immunity 25: 533-543.
12. Welsh RM, Selin LK, Szomolanyi-Tsuda E (2004) Immunological memory to viral infections. Annu. Rev. Immunol. 22: 711-43.
13. El-Sayed NM, Myler PJ, Bartholomeu DC, Nilsson D, Aggarwal G, et al. (2005) The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Sci 309: 409-415.
14. Burns JM Jr, Shreffler WG, Rosman DE, Sleath PR, March CJ, et al. (1992) Identification and synthesis of a major conserved antigenic epitope of Trypanosoma cruzi. PNAS, USA 89: 1239-1243.
15. Ribeirao M, Pereira-Chioccola VL, Rénia L, Filho A, Schenkman S, et al. (2000) Chagasic patients develop a type 1 immune response to Trypanosoma cruzi trans-sialidase. Parasite Immunol 22: 49-53.
16. Frasch ACC (2000) Functional diversity in the trans-sialidase and mucin families in Trypanosoma cruzi. Parasitology Today 16: 282-286.
17. García GA, Arnaiz MR, Esteva MI, Laucella SA, Garavaglia PA, et al. (2007) Evaluation of immune responses raised against Tc13 antigens of Trypanosoma cruzi in the outcome of murine experimental infection. Parasitol 9: 1-11.
18. Millar AE, Wleklinski-Lee M, Kahn SJ (1999) The surface protein superfamily of Trypanosoma cruzi stimulates a polarized Th1 response that becomes anergic. J. Immunol. 162: 6092-6099.
19. Rodrigues MM, Ribeirao M, Pereira-Chioccola V, Renia L, Costa F (1999) Predominance of CD4 Th1 and CD8 Tc1 cells revealed by characterization of the cellular immune response generated by immunization with a DNA vaccine containing a Trypanosoma cruzi gene. Infect. Immun. 67: 3855-3863.
20. + T cell-epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene. Infect. Immun. 69: 5477-5486.
21. + cytotoxic T lymphocytes. J. Immunol. 160: 1817-1823.
22. Martin DL, Tarleton RL (2005) Antigen-specific T cells maintain an effector memory phenotype during persistent Trypanosoma cruzi Infection. J. Immunol. 174: 1594-1601.
23. Wizel B, Palmieri M, Mendoza C, Arana B, Sidney J, et al. (1998) Human infection with Trypanosoma cruzi induces antigen-specific cytotoxic T lymphocyte responses. J. Clin. Invest. 102: 1062-1071.
24. + epitopes recognized by T cells from chronically Trypanosoma cruzi-infected patients. Microbes and Infection 7: 688-697.
25. + T-cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes. PLoS Pathog 2: e77doi. 10.1371/journal.ppat.0020077.
26. Sette A, Sidney J (1999) Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 50: 201-212.
27. Doolan DL, Southwood S, Freilich DA, Sidney J, Graber NL, et al. (2003) Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data. PNAS (USA) 100: 9952-9957.
28. Bertoni R, Sidney J, Fowler P, Chesnut RW, Chisari FV, et al. (1997) Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. J. Clin. Invest. 100: 503-513.
29. Frahm N, Yusim K, Suscovich TJ, Adams S, Sidney J (2007) Extensive HLA class I allele promiscuity among viral CTL epitopes. Eur. J. Immunol. 37: 2419-2433.
30. World Health Organization. Control of Chagas disease (1991) World Health Organ. Tech. Rep. Ser. 811: 1-95.
31. Kuschnir E, Sgammini H, Castro R, Evequoz C, Ledesma R, et al. (1985) Evaluation of cardiac function by radioisotopic angiography, in patients with chronic Chagas cardiopathy. Arq. Bras. Cardiol. 45: 249-56.
32. Parham P, Brodsky FM (1981) Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28. Hum. Immunol. 3: 277-299.
33. Lalvani A, Hill AV (1998) Cytotoxic T-lymphocytes against malaria and tuberculosis: from natural immunity to vaccine design. Clin. Sci. (Colch) 95: 531-538.
34. Chang KM, Gruener NH, Southwood S, Sidney J, Pape GR, et al. (1999) Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C. J. Immunol. 162: 1156-1164.
35. Doolan DL, Hoffman SL, Southwood S, Wentworth PA, Sidney J, et al. (1997) Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. Immunity 7: 97-112.
36. Doolan DLS, Southwood S, Chesnut RW, Appella E, Gomez E, et al. (2000) HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles. J. Immunol. 165: 1123-1137.
37. Threlkeld SC, Wentworth PA, Kalams SA, Wilkes BM, Ruhl DJ, et al. (1997) Degenerate and promiscuous recognition by CTL of peptides presented by the MHC class I A3-like superfamily: implications for vaccine development. J. Immunol. 159: 1648-1657.
38. Sykulev Y, Vugmeyster Y, Brunmark A, Ploegh HL, Eisen HN (1998) Peptide antagonism and T cell receptor interactions with peptide-MHC complexes. Immunity 9: 475-483.
39. Kersh GH, Allen PM (1996) Essential flexibility in the T-cell recognition of antigen. Nature. pp 495-498.
40. Pantaleo G, Harari A (2006) Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases. Nat. Rev. Immunol. pp 417-423.
41. Harari A, Petitpierre S, Vallelian F, Pantaleo G (2004) Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. Blood 103: 966-972.
42. Harari A, Vallelian F, Meylan PR, Pantaleo G (2005) Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. J. Immunol. 174: 1037-1045.
43. Zimmerli SC, Harari A, Cellerai C, Vallelian F, Bart PA, et al. (2005) HIV-1-specific IFN-γ/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. PNAS (USA); 102: 7239-7244.
44. + lymphocyte clones: effect of natural polymorphism on T cell recognition and endogenous cognate antigen presentation by liver cells. Eur. J. Immunol. 30: 3079-3088.
45. Imanishi TTA, Kimura A, Tokunaga K, Gojobori T (1992) In: Proceedings of the Eleventh International Histocompatibility Workshop and Conference (Tokyo). Oxford: Oxford University Press. pp 223-231.
46. Krausa P, Brywka M 3rd, Savage D, Hui KM, Bunce M, et al. (1995) Genetic polymorphism within HLA-A*02: significant allelic variation revealed in different populations. Tissue Antigens 45: 223-231.
47. Santiago-Delpin EA (1991) Histocompatibility profile of selected Latin American countries. Transplant. Proc. 23: 1861-1864.
48. La Gruta NL, Kedzierska K, Pang K, Webby R, Davenport M, et al. (2006) A virus-specific CD8+ T cell immunodominance hierarchy determined by antigen dose and precursor frequencies. PNAS (USA) 103: 994-999.
49. + T cell determinants to enable rational design and characterization of smallpox vaccines 3. J. Exp. Med. 201: 95-104.
50. + T-cell determinants and cross-reactivity in BALB/c mice. J. Virol. 80: 6318-6323.
51. Welsh RM (2006) Private specificities of heterologous immunity. Curr. Opin. Immunol. 18: 331-337.
52. Wherry EJ, Blattman JN, Murali-Krishna K, van der Most R, Ahmed R (2003) Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77: 4911-4927.
53. Appay V, Rowland-Jones SL (2004) Lessons from the study of T-cell differentiation in persistent human virus infection. Semin. Immunol. 16: 205-212.
54. Wherry EJ, Barber DL, Kaech SM, Blattman JN, Ahmed R (2004) Antigen independent memory CD8 T cells do not develop during chronic infection. PNAS (USA) 101: 16004-9.
55. van Baarle D, Tsegaye A, Miedema F, Akbar A (2005) Significance of senescence for virus-specific memory T cell responses: rapid ageing during chronic stimulation of the immune system. Immunology Letters 97: 19-29.
56. Diez H, López MC, Thomas MC, Guzmán F, Rosas F, et al. (2006) Evaluation of IFN-g production by CD8+ T lymphocytes in response to the K1 peptide from KMP-11 protein in patients infected with Trypanosoma cruzi. Parasite Immunol 28: 101-105.
57. Effros RB, Walford RL (1983) Strong HLA-DR expression in T cell cultures after activation is necessary for IL-2-dependent proliferation. Cell Immunol 81: 298-305.
58. Jenkins MK, Taylor PS, Norton SD, Urdahl KB (1991) CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. J. Immunol. 147: 2461-2466.
59. Atwood JA, Weatherly DB, Minning TA, Bundy B, et al. (2005) The Trypanosoma cruzi proteome. Sci 309: 473-476.